Irregular menstruation may predict increased risk of death from ovarian cancer

April 10, 2014, American Association for Cancer Research

(Medical Xpress)—Women with irregular menstrual cycles had a twofold increased risk of death from ovarian cancer, according to a large, prospective study presented here at the AACR Annual Meeting 2014, April 5-9.

"Among reproductive cancers, ovarian cancer is the most common cause of death, because it is usually diagnosed late in the disease process after it has spread," said Barbara A. Cohn, Ph.D., M.P.H., director of the Child Health and Development Studies at the Public Health Institute in Berkeley, Calif. "Unfortunately, there is no reliable method for early diagnosis or screening, and symptoms like abdominal pain and bloating often do not come to a woman's attention until the cancer has spread.

"In this large, prospective study, we found that those who had had a 2.4-fold of death due to ovarian cancer," Cohn added. "This information may help earlier diagnosis and perhaps lead to a strategy to prevent ovarian cancer by pointing toward how the cancer develops and spreads.

"It is notable that the 2.4-fold increase in risk of ovarian cancer death we observed for women with irregular/infrequent cycles in this study is close to the threefold increase in risk observed for women with a family history of ovarian cancer in a first-degree relative," explained Cohn. "Our study finding could lead to better understanding of the 90 percent of that occur in women with no family history of ovarian cancer and with no known high-risk inherited mutations."

Between 1959 and 1967, the Child Health and Development Studies enrolled more than 15,000 pregnant women and followed them for more than 50 years to study factors impacting health during pregnancy. This report is based on 14,403 women who had a single live birth. Cohn and colleagues used medical reports and self-reported data from these women on their menstrual irregularity, including those whose cycles were longer than 35 days, and those who had anovulation. The researchers used this information as a proxy for (PCOS).

Of these women, 13 percent reported menstrual irregularities when they were about 26 years of age and 64 of them died from ovarian cancer, around 69 years of age.

The association between menstrual irregularities and ovarian cancer death was independent of age, race, parity, and weight, and this association was stronger after the women reached their mid-60s, about 40 years after they entered the study, according to Cohn. The researchers ruled out use of fertility drugs or contraceptives prior to pregnancy as an explanation for their findings. An advantage of the study was that infertility was ruled out as an explanation for findings since all women in the study had achieved a live birth, she added.

They also found that when the data were analyzed by ovarian cancer type, menstrual irregularities increased risk for serous-type cancers and for endometrioid-type cancers by nearly threefold and fourfold, respectively. The sample size for endometrioid-type ovarian cancer was small and needs further evaluation in a larger group of women, said Cohn.

The researchers also found that the incidence of late-stage ovarian cancer was twofold higher for with irregular or infrequent menstrual cycles, and this finding was consistent with their higher risk for death from ovarian cancer.

Findings from this study are contrary to the existing expectation that PCOS, which is characterized by less frequent ovulation and irregular or long , would protect the ovary. But infrequent ovulation is not the only hallmark of PCOS, and there are a number of anatomical, hormonal, and metabolic abnormalities associated with PCOS that might explain the study findings, said Cohn.

Explore further: Could daughter's cancer risk be affected by father's age at birth?

Related Stories

Could daughter's cancer risk be affected by father's age at birth?

April 8, 2014
(HealthDay)—A father's age at the time of his daughter's birth may affect her risk for breast, ovarian and endometrial cancer in adulthood, a new study suggests.

Women urged to recognise the signs of ovarian cancer

March 12, 2014
(Medical Xpress)—Feeling bloated most days for three weeks or more is the focus of a new Be Clear on Cancer campaign being launched by Public Health England in the North West.

Daily aspirin may guard against ovarian cancer

February 6, 2014
(HealthDay)—Taking aspirin every day might lower a woman's risk of developing ovarian cancer by one-fifth, a new study suggests.

​Screening reveals additional link between endometriosis and ovarian cancer

April 4, 2014
(Medical Xpress)—Some women with endometriosis, a chronic inflammatory disease, are predisposed to ovarian cancer, and a genetic screening might someday help reveal which women are most at risk, according to a University ...

Average-risk women overestimate ovarian cancer risk

March 11, 2014
(HealthDay)—Average-risk, postmenopausal women overestimate their risk of ovarian cancer, but report low cancer worry, according to a study published in the March issue of the American Journal of Obstetrics and Gynecology.

Ovarian cancer survivor backs study to improve screening

April 4, 2014
A woman from Manchester has warned other women of the need to be aware of ovarian cancer, especially if you have a family history of the disease, as part of Ovarian Cancer Awareness Month.

Recommended for you

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.